These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2796052)

  • 1. [Fibrin deposition and fibrinolysis in the pathogenesis of pulmonary fibrosis].
    Ikeda T; Hirose N; Koto H; Hirano H; Shigematsu N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Apr; 27(4):448-51. PubMed ID: 2796052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial reversal of established bleomycin-induced pulmonary fibrosis by rh-urokinase in a rat model.
    Hart DA; Whidden P; Green F; Henkin J; Woods DE
    Clin Invest Med; 1994 Apr; 17(2):69-76. PubMed ID: 7516275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits.
    Günther A; Lübke N; Ermert M; Schermuly RT; Weissmann N; Breithecker A; Markart P; Ruppert C; Quanz K; Ermert L; Grimminger F; Seeger W
    Am J Respir Crit Care Med; 2003 Dec; 168(11):1358-65. PubMed ID: 14644925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.
    Fujimoto H; Gabazza EC; Taguchi O; Nishii Y; Nakahara H; Bruno NE; D'Alessandro-Gabazza CN; Kasper M; Yano Y; Nagashima M; Morser J; Broze GJ; Suzuki K; Adachi Y
    Am J Pathol; 2006 Apr; 168(4):1086-96. PubMed ID: 16565485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system.
    Swaisgood CM; French EL; Noga C; Simon RH; Ploplis VA
    Am J Pathol; 2000 Jul; 157(1):177-87. PubMed ID: 10880388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse.
    Olman MA; Mackman N; Gladson CL; Moser KM; Loskutoff DJ
    J Clin Invest; 1995 Sep; 96(3):1621-30. PubMed ID: 7544811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of bleomycin-induced pulmonary fibrosis by transfer of urokinase-type plasminogen activator genes.
    Sisson TH; Hattori N; Xu Y; Simon RH
    Hum Gene Ther; 1999 Sep; 10(14):2315-23. PubMed ID: 10515451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endotoxin-induced intravascular coagulation in rabbits: effect of tissue plasminogen activator vs urokinase of PAI generation, fibrin deposits and mortality.
    Paloma MJ; Páramo JA; Rocha E
    Thromb Haemost; 1995 Dec; 74(6):1578-82. PubMed ID: 8772240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
    Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E
    J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation of experimental pulmonary fibrosis by intravenous immunoglobulin (IVIG).
    Molina V; Haj-Yahia S; Solodeev I; Levy Y; Blank M; Shoenfeld Y
    Autoimmunity; 2006 Dec; 39(8):711-7. PubMed ID: 17178568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of Fuzheng Huayu recipe on MMP-2 activity and type IV collagen expression at fibrotic lung].
    Tan SZ; Liu CH; Zhang W; Lu X; Ye WC; Cai ZZ; Liu P
    Zhongguo Zhong Yao Za Zhi; 2007 May; 32(9):835-9. PubMed ID: 17639988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin attenuates bleomycin-induced pulmonary fibrosis in mice.
    Ou XM; Feng YL; Wen FQ; Huang XY; Xiao J; Wang K; Wang T
    Chin Med J (Engl); 2008 Sep; 121(18):1821-9. PubMed ID: 19080365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of bleomycin-induced lung fibrosis in rats by mesna.
    El-Medany A; Hagar HH; Moursi M; At Muhammed R; El-Rakhawy FI; El-Medany G
    Eur J Pharmacol; 2005 Feb; 509(1):61-70. PubMed ID: 15713430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A preliminary study of CTGF in bleomycin-induced mouse pulmonary fibrosis].
    Zhang L; Lu HP; Lai GX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):290-2. PubMed ID: 15862142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis.
    Higashiyama H; Yoshimoto D; Kaise T; Matsubara S; Fujiwara M; Kikkawa H; Asano S; Kinoshita M
    Exp Mol Pathol; 2007 Aug; 83(1):39-46. PubMed ID: 17274978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
    Camiolo SM; Greco WR
    Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive effect of melatonin on bleomycin-induced lung fibrosis in rats.
    Yildirim Z; Kotuk M; Erdogan H; Iraz M; Yagmurca M; Kuku I; Fadillioglu E
    J Pineal Res; 2006 Jan; 40(1):27-33. PubMed ID: 16313495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice.
    Chen XH; Sun RS; Hu JM; Mo ZY; Yang ZF; Jin GY; Guan WD; Zhong NS
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):146-53. PubMed ID: 18785980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine.
    Nici L; Santos-Moore A; Kuhn C; Calabresi P
    Cancer; 1998 Nov; 83(9):2008-14. PubMed ID: 9806661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.